So when the half year report comes in and assumably reflects the downgraded guidance, do we think the confirmation through actual results will further push the price down?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025